SMTL ID : 5dtm.2 (1 other biounit)

Crystal structure of Dot1L in complex with inhibitor CPD1 [4-(2,6-dichlorobenzoyl)-N-methyl-1H-pyrrole-2-carboxamide]

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x 5F4: 4-(2,6-dichlorobenzoyl)-N-methyl-1H-pyrrole-2-carboxamide(Non-covalent)

5F4.1: 13 residues within 4Å: Chain A: F.132, S.141, L.144, V.145, F.240, V.241, N.242, F.244, V.268, S.269, S.270, S.312, Y.313 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:L.144, A:V.145, A:F.240, A:F.240, A:V.268, A:Y.313 Hydrogen bonds: A:S.312 Water bridges: A:N.242, A:N.242, A:S.312 pi-Stacking: A:F.132 Halogen bonds: A:V.241

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Scheufler, C. et al., Optimization of a Fragment-Based Screening Hit toward Potent DOT1L Inhibitors Interacting in an Induced Binding Pocket. Acs Med.Chem.Lett. (2016)

Release Date

2016-06-15

Peptides

Histone-lysine N-methyltransferase, H3 lysine-79 specific: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Histone-lysine N-methyltransferase, H3 lysine-79 specific

Related Entries With Identical Sequence